⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28352124 | 0.83 | — | — | |
| SCHEMBL17333304 | 0.77 | — | — | |
| SCHEMBL14715168 | 0.72 | — | — | |
| SCHEMBL28996123 | 0.69 | — | — | |
| SCHEMBL28373848 | 0.67 | — | — | |
| SCHEMBL28751197 | 0.67 | — | — | |
| SCHEMBL751498 | 0.67 | — | — | |
| SCHEMBL6660494 | 0.62 | — | — | |
| SCHEMBL752991 | 0.61 | — | — | |
| SCHEMBL31167602 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117219773-A | Positive electrode slurry and preparation method thereof | 宁波容百新能源科技股份有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-118338916-A | Multifunctional compounds for use in medical imaging and therapy | 安特络手术解决方案公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-117219773-A | Positive electrode slurry and preparation method thereof | 宁波容百新能源科技股份有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-107805308-B | Dynamic polymer with hybrid cross-linked network and application thereof | 翁秋梅 | 2022-04-15 | — | — | CN | disclosed |
| CN-107805311-B | Dynamic polymer with hybrid cross-linked network and application thereof | 翁秋梅 | 2022-04-01 | — | — | CN | disclosed |
| CN-107446135-B | Dynamic polymer with dynamic cross-linked structure | 翁秋梅 | 2020-04-10 | — | — | CN | disclosed |
| WO-2009046098-A1 | NOVEL CYCLIC BORONATE INHIBITORS OF HCV REPLICATION | SMITHKLINE BEECHAM CORPORATION (US) | 2009-04-09 | — | — | WO | disclosed |